 | Verona Pharma plc Forecasted to Post Q1 2022 Earnings of ($0.40) Per Share (NASDAQ:VRNA)
americanbankingnews.com - May 5 at 4:38 AM |
| Verona Pharma (NASDAQ:VRNA) PT Lowered to $18.00
americanbankingnews.com - May 3 at 12:09 PM |
| FY2025 EPS Estimates for Verona Pharma plc Boosted by Analyst (NASDAQ:VRNA)
americanbankingnews.com - May 3 at 4:52 AM |
| Brokers Set Expectations for Verona Pharma plc's Q1 2022 Earnings (NASDAQ:VRNA)
americanbankingnews.com - May 3 at 4:18 AM |
 | Verona Pharma Reports First Quarter 2021 Financial Results and Provides Corporate Update
finance.yahoo.com - April 29 at 7:49 AM |
| Verona Pharma plc (NASDAQ:VRNA) Sees Large Growth in Short Interest
americanbankingnews.com - April 29 at 1:28 AM |
| Verona Pharma Announces Publication of Phase 2b Dose-Ranging COPD Data in the International Journal of Chronic Obstructive Pulmonary Disease
finance.yahoo.com - April 27 at 8:32 AM |
| Analysts Anticipate Verona Pharma plc (NASDAQ:VRNA) Will Announce Earnings of -$0.45 Per Share
americanbankingnews.com - April 24 at 8:12 AM |
| Zacks: Brokerages Anticipate Verona Pharma plc (NASDAQ:VRNA) to Announce -$0.45 Earnings Per Share
americanbankingnews.com - April 24 at 8:12 AM |
| Verona Pharma Reports Results of Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
finance.yahoo.com - April 23 at 6:16 AM |
|
| Verona Pharma (VRNA) Set to Announce Earnings on Thursday
americanbankingnews.com - April 22 at 4:06 AM |
 | Revisiting Verona Pharmaceuticals
seekingalpha.com - March 2 at 7:39 AM |
| Verona Pharma plc 2020 Q4 - Results - Earnings Call Presentation
seekingalpha.com - February 26 at 1:49 PM |
 | Verona Pharma to Report Fourth Quarter and Full Year 2020 Financial Results and Provide Corporate Update
markets.businessinsider.com - February 18 at 2:29 AM |
 | Verona Pharma's pMDI Ensifentrine Shows Improved Lung Function In Mid-Stage COPD Study
msn.com - February 2 at 7:25 AM |
| CORRECTING and REPLACING -- Verona Pharma Reports Positive Phase 2 Results with pMDI Formulation of Ensifentrine in COPD
finance.yahoo.com - February 2 at 7:25 AM |
| Verona Pharma Completes Enrollment in Pilot Study of pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
finance.yahoo.com - January 14 at 3:02 AM |
| Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
finance.yahoo.com - January 5 at 7:21 AM |
 | Verona Pharma to Present at H.C. Wainwright Virtual BioConnect Conference
feeds.benzinga.com - January 5 at 2:32 AM |
| News for Verona Pharma PLC Registered Shs
markets.businessinsider.com - December 24 at 9:51 AM |
| Is VRNA A Good Stock To Buy Now?
finance.yahoo.com - December 11 at 3:05 PM |
| 25 Best U.S. Cities to Live With Asthma
finance.yahoo.com - November 25 at 12:00 AM |
| Verona Pharma Secures up to $30 Million Debt Financing from Silicon Valley Bank
finance.yahoo.com - November 23 at 9:30 AM |
| Verona Pharma EPS beats by $0.15
seekingalpha.com - October 30 at 3:10 PM |
| Verona Pharma Plcto Host Earnings Call
finance.yahoo.com - October 29 at 12:31 PM |
| Verona Pharma plc Operational Update and Financial Results for the Three and Nine Months Ended September 30, 2020
finance.yahoo.com - October 29 at 7:31 AM |
| Verona COPD Trial, And Other News: The Good, Bad And Ugly Of Biopharma
seekingalpha.com - October 27 at 7:42 AM |
| Verona Pharma plc (I9S1.SG)
in.finance.yahoo.com - October 11 at 5:07 PM |
 | Verona Pharma plc Rings the Closing Bell
nasdaq.com - September 21 at 2:30 PM |
| Intended Delisting and Cancellation of Ordinary Shares from Trading on AIM
finance.yahoo.com - September 21 at 4:05 AM |
| Verona Pharma Announces Publication of Phase 2b COPD Symptom Data in the International Journal of Chronic Obstructive Pulmonary Disease
finance.yahoo.com - September 16 at 8:39 AM |
| Verona Pharma commences pMDI ensifentrine study in COVID-19 patients in the U.S.
seekingalpha.com - September 8 at 10:32 AM |
|
| Verona Pharma Initiates Pilot Study with pMDI Ensifentrine in U.S. Patients Hospitalized with COVID-19
finance.yahoo.com - September 8 at 5:32 AM |
| Verona Pharma plc (VRNA)
in.finance.yahoo.com - August 14 at 2:17 PM |
| Verona Pharma plc (VRNA) CEO David Zaccardelli on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 14 at 2:17 PM |
| Verona Pharma plc: TR-1: Standard form for notification of major holdings
finance.yahoo.com - July 27 at 7:20 AM |
| Closing of Financing, Issued Share Capital and Total Voting Rights
finance.yahoo.com - July 22 at 2:03 PM |
| Stock Alert: Verona Pharma Loses 14%
www.nasdaq.com - July 20 at 12:57 PM |
| Stock Alert: Verona Pharma Trading 85% Higher
markets.businessinsider.com - July 20 at 12:40 AM |
| Verona Pharma raises $200M financing
seekingalpha.com - July 17 at 12:00 PM |
| Verona Pharma Raises $200 Million in Oversubscribed Private Placement and Subscription
finance.yahoo.com - July 17 at 7:00 AM |
| Hedge Funds Are Crazy About Bassett Furniture Industries Inc. (BSET)
finance.yahoo.com - July 8 at 11:15 PM |
| VRNA Verona Pharma plc American Depositary Share
www.nasdaq.com - May 15 at 7:02 PM |
| Verona Pharma Announces FDA Response to End-of-Phase 2 Briefing Package for Ensifentrine in COPD and Outlines Phase 3 ENHANCE Clinical Program
finance.yahoo.com - May 14 at 4:08 AM |
| Verona Pharma down 30% on uncertainty with Phase 3 ensifentrine study
seekingalpha.com - May 2 at 9:16 AM |
| Verona Pharma plc (VRNA) CEO David Zaccardelli on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 1 at 11:14 PM |
| Verona Pharma Presents Expanded Analysis of Ensifentrine Clinical Data in COPD Maintenance Treatment at the American Thoracic Society 2020 International Conference
finance.yahoo.com - May 1 at 6:14 PM |
| Verona Pharma plc: Operational Update and Financial Results for the Three Months Ended March 31, 2020
finance.yahoo.com - April 30 at 6:02 AM |
| Verona Pharma to Announce Financial Results for the Three Months Ended March 31, 2020 and Provide Corporate Update
finance.yahoo.com - April 23 at 7:09 AM |
| Will Verona Pharma Continue to Surge Higher?
finance.yahoo.com - April 17 at 2:00 PM |
